Targeting bacterial surface structures to fight antibiotic resistance
Bacteriology Core
This study is working on creating special antibodies that can help your body fight off tough infections caused by bacteria that don't respond to regular antibiotics, like some strains of Staphylococcus aureus and Neisseria gonorrhoeae, with the hope of offering better treatment options for patients dealing with these stubborn infections.
Quick facts
| Grant type | P01 program project |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Scripps Research Institute, the NIH-funded |
| Lab location | 1 site (La Jolla, United States) |
| Project ID | NIH-11082425 on NIH RePORTER |
What this research studies
This research focuses on developing antibodies that specifically target glycans on the surface of harmful bacteria, such as antibiotic-resistant strains of Staphylococcus aureus and Neisseria gonorrhoeae. By creating these targeted antibodies, the research aims to enhance the body's ability to combat infections caused by these resistant pathogens. The approach includes testing the effectiveness of these antibodies in laboratory assays and in animal models to determine their potential in treating serious bacterial infections. Patients may benefit from new treatment options that could be more effective against antibiotic-resistant infections.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals suffering from infections caused by antibiotic-resistant bacteria, particularly those with severe or recurrent infections.
Not a fit: Patients with infections caused by non-bacterial pathogens or those who do not have antibiotic-resistant infections may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to new antibody therapies that effectively treat infections caused by antibiotic-resistant bacteria.
How similar studies have performed: Previous research has shown promise in using targeted antibodies to combat bacterial infections, indicating that this approach could be effective.
Where this research is happening
La Jolla, United States
- Scripps Research Institute, the — La Jolla, United States (Active)
Researchers
- Principal investigator: Horswill, Alexander R — Scripps Research Institute, the
- Study coordinator: Horswill, Alexander R
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.